文献速递产科麻醉心胸血管麻醉

卡贝缩宫素剂量对健康产妇脊髓麻醉下剖宫产时跨壁复极离散度的影响

The Effect of Carbetocin Dose on Transmural Dispersion of Myocardial Repolarization in Healthy Parturients Scheduled for Elective Cesarean Delivery Under Spinal Anesthesia: A Prospective, Randomized Clinical Trial.
PubMed 文献 · Anesth Analg · 2021-01-01

这项前瞻性随机临床试验纳入50名健康产妇,在脊髓麻醉下剖宫产时随机接受卡贝缩宫素50 µg或100 µg静脉推注。结果显示100 µg组给药后5分钟Tp-e较50 µg组延长4.1毫秒,50 µg组Tp-e较基线无显著变化,两组QTc均显著延长但无组间差异,无心律失常发生。

核心结论

  • 健康产妇脊髓麻醉下剖宫产术后给予卡贝缩宫素50 µg静脉推注不影响Tp-e,100 µg仅轻微延长Tp-e。
  • 卡贝缩宫素给药后QTc显著延长,但无 apparent 剂量依赖性效应。
  • 较高剂量下Tp-e的轻微延长不太可能对跨壁复极离散度产生临床显著影响,诱发尖端扭转型室速的风险低。

研究设计与样本

  • 前瞻性、随机临床试验,纳入50名择期剖宫产的健康产妇,采用标准化脊髓麻醉和去氧肾上腺素输注。
  • 产妇随机接受卡贝缩宫素50 µg(C50)或100 µg(C100)经输液泵1分钟静脉推注。
  • 在基线、脊髓麻醉后5分钟、卡贝缩宫素给药后5和10分钟采集12导联心电图,由对分组和心电图时间盲法的心脏病学家按Emori标准测量QTc和Tp-e。
  • 主要结局为卡贝缩宫素给药后5分钟Tp-e在C50与C100组间及组内与基线的变化。

主要发现

  • 41名产妇数据纳入分析,平均(标准差)年龄39.0(0.7)岁,体重75.0(12.0)kg。
  • 无心律失常发生。

关键数值与推荐

  • Tp-e测量采用Emori标准。

临床怎么用

  • 健康产妇脊髓麻醉下剖宫产使用卡贝缩宫素50 µg静脉推注时,Tp-e未见显著延长。
  • 使用100 µg卡贝缩宫素时Tp-e仅轻微延长,临床诱发尖端扭转型室速的风险低。
  • 卡贝缩宫素给药后QTc显著延长,临床应关注QT间期变化,但本研究未显示剂量依赖性效应。

局限性

  • 研究仅纳入健康产妇,结果不能外推至合并心脏病或其他QT间期延长危险因素的产妇。
  • 样本量较小,最终仅41名产妇数据纳入分析。
  • 仅评估了50 µg和100 µg两个剂量,未涉及其他剂量。
  • 观察时间仅至卡贝缩宫素给药后10分钟,未评估更长期的心电图变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: QT interval prolongation is associated with torsade de pointes but remains a poor predictor of drug torsadogenicity. Increased transmural dispersion of myocardial repolarization (TDR), measured as the time interval between the peak and end of the T wave (Tp-e), is a more reliable predictor. Carbetocin is recommended as an uterotonic in patients undergoing cesarean delivery (CD), but its effect on Tp-e is unknown. We evaluated the effect of carbetocin dose on Tp-e and Bazett-corrected QT intervals (QTc) during elective CD under spinal anesthesia. METHODS: On patient consent, 50 healthy parturients undergoing elective CD with a standardized spinal anesthetic and phenylephrine infusion were randomized to receive an intravenous (IV) bolus of carbetocin 50 µg (C50) or 100 µg (C100) via an infusion pump over 1 minute. A 12-lead electrocardiogram (ECG) was obtained at baseline, 5 minutes after spinal anesthesia, then 5 and 10 minutes after carbetocin administration. A cardiologist blinded to group and timing of ECGs measured QTc and Tp-e using Emori's criteria. Primary outcome was the change in Tp-e at 5 minutes after carbetocin administration between the C50 and C100 groups and within each group compared to baseline values. Secondary outcomes included occurrence of arrhythmias, changes in QTc at 5 and 10 minutes after carbetocin, changes in both QTc and Tp-e after spinal anesthesia compared to baseline between and within groups. RESULTS: Data from 41 parturients with a mean (standard deviation [SD]) age of 39.0 (0.7) years and weight of 75.0 (12.0) kg were analyzed. Between groups, at 5 minutes after carbetocin administration, Tp-e in C100 was 4.1 milliseconds longer compared to C50 (95% confidence interval [CI], 0.8-7.5; P = .01). Within groups, at 5 minutes after carbetocin administration, C50 did not significantly increase Tp-e compared to baseline (mean difference [MD] 1.9 milliseconds; 95% CI, -0.95 to 4.81 milliseconds; P = .42) but C100 did (MD 5.1 milliseconds; 95% CI, 2.1-8.1; P = .003). QTc increased significantly within C50 and C100 groups at 5 and 10 minutes after carbetocin administration (all P < .001), with no between-group differences. There were no arrhythmias. CONCLUSIONS: Tp-e was unaffected by C50 IV given after CD in healthy parturients under spinal anesthesia, but minimally prolonged by C100. The increase in QTc after carbetocin administration was statistically significant, but with no apparent dose-dependent effect. The minimal Tp-e prolongation at the higher dose is unlikely to have any clinically significant impact on TDR and therefore the risk of inducing torsade de pointes is low.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Clunies-Ross N, Roston TM, Taylor J, et al. The Effect of Carbetocin Dose on Transmural Dispersion of Myocardial Repolarization in Healthy Parturients Scheduled for Elective Cesarean Delivery Under Spinal Anesthesia: A Prospective, Randomized Clinical Trial. Anesth Analg. 2021. PMID: 32149759. doi:10.1213/ANE.0000000000004712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。